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Background
The mechanisms of immune escape from neutralizing
antibody are not fully understood for primary HIV-1 iso-
lates with R5 phenotype. Using two different conditions
of the anti-V3 humanized monoclonal antibody (MAb)
KD-247 for selecting escape mutants we analyzed the
mechanism of escape pathway of a primary R5 virus.
Methods
We induced escape variants by exposing a neutralization-
sensitive primary R5 isolate, HIV-1MTA to increasing con-
centrations of KD-247 in PM1/CCR5 cells. The virus was
initially exposed 1 or 0.05 μg/ml of KD-247 and was seri-
ally passaged up to 1000 μg/ml. We determined the
changes in the amino acid (aa) sequences of gp120-
encoding region at each passage and monitored neutrali-
zation sensitivity of the passaged virus by WST-8 assay. To
compare replication fitness of the escape mutants a com-
petition assay was performed in the presence or absence of
KD-247.
Results
Under high KD-247 pressure (1 μg/ml), a substitution of
aa in V3 tip (GPGR→GQGR, MTAP313Q) was observed at
passage 2 (p2) and was subsequently detected in virtually
all the clones examined at p5 (20 μg/ml). On the other
hand, under relatively low KD-247 pressure (0.05 μg/ml),
another substitution in V3 tip (GPGR→GPGK, MTAR315K)
was emerged at p5 (0.4 μg/ml) and was dominated in vir-
tually all subsequent clones at p14 (10 μg/ml). These
escape mutants were found to have highly resistant phe-
notype to KD-247. A series of competition assay of the
mutants revealed that MTAR315K replicates better than
MTAP313Q in the absence of KD-247. On the other hand,
MTAP313Q dominated over MTAR315K in the presence of
KD-247.
Conclusion
The viral fitness to the cell and the resistance to the spe-
cific antibodies are major factors contributing the virus
escape from neutralizing antibodies. Our results demon-
strated the primary R5 isolate HIV-1MTA underwent differ-
ent escape pathway dependent on the concentration of
the antibody.
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